NRIX P/B: current value, 10-year range and year-by-year history
Cash & Leverage
NRIX's p/b is higher than 65% of the last 10 years.
P/B History
NRIX P/B by year
Yearly range of NRIX’s p/b from 2020 to 2026. Over the full period it ranged from 1.0 to 9.5, averaging 3.1.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 2.7 | 4.2 | 7.7 | 3.3 |
| 2025 | 1.5 | 2.4 | 4.0 | 3.3 |
| 2024 | 2.1 | 3.9 | 5.7 | 2.8 |
| 2023 | 1.0 | 1.9 | 2.9 | 2.8 |
| 2022 | 1.2 | 2.2 | 3.9 | 2.0 |
| 2021 | 2.5 | 4.0 | 6.7 | 3.8 |
| 2020 | 1.3 | 3.7 | 9.5 | 4.4 |
Get notified when NRIX P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is NRIX P/B High or Low Right Now?
Nurix Therapeutics, Inc.'s P/B is currently 3.3, which is above average relative to its 10-year historical range. The 10-year median P/B for NRIX is approximately 2.8. See all NRIX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.